Scynexis (SCYX) Change in Receivables (2013 - 2023)
Scynexis' (SCYX) quarterly Change in Receivables came in at -$2.2 million in Q4 2023, down 472.7% YoY from $602354.6 in Q4 2022, and down 2167.68% on a QoQ basis from -$99000.0 in Q3 2023.
Scynexis (SCYX) Change in Receivables (2013 - 2023) Analysis & Trends
Scynexis (SCYX) has 5 years of Change in Receivables data on file, last reported at -$2.2 million in Q4 2023.
- Quarterly Change in Receivables fell 472.7% year-over-year to -$2.2 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$2.2 million (down 805.24% YoY) and the FY2023 annual result came in at -$2.1 million, down 269.44% from the prior year.
- Change in Receivables slipped to -$2.2 million in Q4 2023, from -$99000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $284000.0 in Q2 2023 to a low of -$2.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2.25 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Sep 30, 2023 | -99,000.00 |
| Sep 30, 2023 | -99,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Dec 31, 2015 | -554,000.00 |
| Dec 31, 2015 | -554,000.00 |
| Sep 30, 2015 | 309,000.00 |
| Sep 30, 2015 | 309,000.00 |
| Jun 30, 2015 | 662,000.00 |
| Jun 30, 2015 | 662,000.00 |
| Mar 31, 2015 | -448,000.00 |
| Mar 31, 2015 | -448,000.00 |